Manufacturer of Controlled Substances; Notice of Registration, 8112 [05-3028]
Download as PDF
<![CDATA[
8112
Federal Register / Vol. 70, No. 32 / Thursday, February 17, 2005 / Notices
Agreement may also be obtained by mail
from the Consent Decree Library, P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611 or by
faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
a fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $2.25 (25 cents per
page reproduction cost), payable to the
U.S. Treasury.
Ronald Gluck,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 05–3013 Filed 2–16–05; 8:45 am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Notice of Lodging of Consent Decree
Under the Comprehensive
Environmental Response,
Compensation, and Liability Act
In accordance with 28 U.S.C. 50.7,
notice is hereby given that on January
31, 2005, a proposed consent Decree in
United States v. Thomasville Furniture
Industries, Inc. et al., Civ. No.
6:05CV00001, was lodged with the
United States District Court for the
Western District of Virginia.
The proposed consent decree would
resolve the United States’ claims, on
behalf of the Environmental Protection
Agency (‘‘EPA’’), under Section 107(a)
of the Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’), 42 U.S.C. 9607(a),
against Thomasville Furniture
Industries, Inc., (‘‘Thomasville’’), Univar
U.S.A., Inc. (‘‘Univar’’), and
Buckingham County, a political
subdivision of the Commonwealth of
Virginia, to recover costs incurred by
the United States in performing
response actions at the Buckingham
County Landfill Superfund Site (‘‘Site’’)
in Dillwyn, Virginia as set forth in the
terms of the decree.
Both Thomasville and Univar are
liable for the United States’ response
costs under Section 107(a)(3) of
CERCLA, 42 U.S.C. 9607(a)(3), because
they, or their predecessors, arranged for
disposal of CERCLA listed hazardous
materials at the Site which led to a
release of hazardous substances causing
EPA to incur response costs.
Buckingham County is liable for the
United States’ response costs under
Section 107(a)(1) of CERCLA, 42 U.S.C.
9607(a)(1), as the current owner and
operator of the Site.
VerDate jul<14>2003
14:41 Feb 16, 2005
Jkt 205001
Under the terms of the Consent
Decree, Thomasville, Univar, and
Buckingham County have agreed to pay
$1,976,000 of EPA’s unreimbursed
response costs of $2,052,458.26 at the
Site. The United States has reserved its
right to pursue an additional $171,688,
incurred to implement a discrete drum
removal action at the Site in 1999, from
Buckingham County in a separate
action. The proposed settlement
addresses past costs only, and thus the
Consent Decree reserves all parties’
rights with regard to future costs, except
for the Defendants’ statute of limitations
defenses.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Consent Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to United
States v. Thomasville Furniture
Industries, Inc. et al., Civ. No.
6:05CV00001, D.J. Ref. 90–11–2–07971.
The Consent Decree may be examined
at the Office of the United States
Attorney for the Western District of
Virginia, 105 Franklin Road, SW., Suite
1, Roanoke, VA 24011. During the
public comment period, the Consent
Decree may also be examined on the
following Department of Justice Web
site, https://www.usdoj.gov/enrd/
open.html. A copy of the Consent
Decree may also be obtained by mail
from the Consent Decree Library, P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611 or by
faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy of the Consent Decree
from the Consent Decree Library, please
enclose a check in the amount of $22.50
(90 pages at 25 cents per page
reproduction cost) payable to the U.S.
Treasury.
Robert D. Brook,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 05–3011 Filed 2–16–05; 8:45 am]
BILLING CODE 4410–15–M
PO 00000
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 18, 2004, and
published in the Federal Register on
October 25, 2004, (69 FR 62295), Cody
Laboratories, Inc., 301 Yellowstone
Avenue, Cody, Wyoming 82414, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
the basic class of controlled substances
listed in Schedule II:
Drug
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Cocaine (9041) .............................
Oxycodone (9143) ........................
Dihydromorphine (9145) ...............
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Meperidine (9230) ........................
Oxymorphone (9652) ...................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of Cody
Laboratories, Inc. to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Cody Laboratories, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–3028 Filed 2–16–05; 8:45 am]
BILLING CODE 4410–09–P
Frm 00057
Schedule
E:\FR\FM\17FEN1.SGM
17FEN1
]]>Agencies
[Federal Register Volume 70, Number 32 (Thursday, February 17, 2005)]
[Notices]
[Page 8112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3028]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 18, 2004, and published in the Federal
Register on October 25, 2004, (69 FR 62295), Cody Laboratories, Inc.,
301 Yellowstone Avenue, Cody, Wyoming 82414, made application by
renewal to the Drug Enforcement Administration (DEA) for registration
as a bulk manufacturer of the basic class of controlled substances
listed in Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Cocaine (9041)............................. II
Oxycodone (9143)........................... II
Dihydromorphine (9145)..................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Meperidine (9230).......................... II
Oxymorphone (9652)......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cody Laboratories, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cody Laboratories, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: February 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-3028 Filed 2-16-05; 8:45 am]
BILLING CODE 4410-09-P
